In Canada/nursing study

Nursing Medication Card - Quetiapine (Seroquel)(Kor/Eng)

Shannon.p 2025. 5. 26. 07:19
반응형

Quetiapine (Seroquel)

  • 적응증: 조현병, 양극성 장애, 우울증 보조요법
  • 작용 기전: 도파민 및 세로토닌 수용체 길항
  • 흡수와 대사: 장에서 흡수, 간 CYP3A4 대사, 신장 배설
  • 부작용: 졸음, 체중 증가, 저혈압, QT 연장
  • 투여량: 초기 50mg, 증량 후 300–800mg/일
  • 간호 고려사항: 활력징후 모니터링 (혈압, 맥박), ECG 모니터링, 졸림으로 인한 낙상 주의

Quetiapine (Seroquel)

  • 분류: 비정형 항정신병제
  • 적응증: 조현병, 양극성 장애, 우울증
  • 부작용: 졸림, 체중 증가, 기립성 저혈압
  • 간호 포인트: 자살 경향 모니터링, 기립성 저혈압 예방 위해 천천히 일어나기

QUEtiapine (SEROquel) [kwuh tai ah peen] 

Antipsychotics, mood stabilizers 

Indications: schizophrenia, depressive episodes w/ bipolar disorder, acute manic episodes associated w/ bipolar disorder, maintenance treatment of bipolar 1 disorder, adjunctive treatment of depression 

Therapeutic effects: decreased manifestations of psychoses, depression, or acute mania 

Absorption: well ac PO 

Distribution: wide 

Metabolism&Excretion: by liver, <1% unchanged in urine 

ADE: CNS; neuroleptic malignant syndrome, seizures Derm; drug reaction w/ eosinophilia and systemic symptoms, stevens-johnson syndrome GI; gi obstruction, pancreatitis Hemat; agranulocytosis, decreased Hb

Dose: PO; 25 mg BID on day1, up by 25-50 mg 2-3/day on day2 and 3, up to 300-400 mg/day in 2-3 divided by day 4 

Quetiapine (Seroquel)

  • Indications: Schizophrenia, bipolar disorder, major depressive disorder (adjunctive therapy).
  • Therapeutic Effects: Antagonist at multiple neurotransmitter receptors, including serotonin and dopamine.
  • Absorption: Well absorbed orally; peak plasma concentration in 1.5 hours.
  • Distribution: Extensive distribution; 83% plasma protein binding.
  • Metabolism & Excretion: Hepatic metabolism via CYP3A4; excreted in urine and feces.
  • Adverse Effects: Sedation, weight gain, orthostatic hypotension, dry mouth.
  • Dose: Initial: 50 mg/day; titrated to 300–400 mg/day in divided doses.
  • Considerations: Monitor for metabolic syndrome; assess for extrapyramidal symptoms.MedscapeMedscape
반응형